ORF135 Antibody

What is E. coli ORF135 and why is it significant in nucleotide metabolism research?

Orf135 from Escherichia coli is a member of the Nudix (nucleoside diphosphate linked to some other moiety, x) hydrolase family of enzymes with substrate specificity for CTP, dCTP, and 5-methyl-dCTP. Unlike other nucleoside triphosphate pyrophophohydrolases of the Nudix family discovered thus far, Orf135 is highly specific for pyrimidine (deoxy)nucleoside triphosphates .

The enzyme cleaves its substrates to produce a nucleoside monophosphate and inorganic pyrophosphate, has an alkaline pH optimum, and requires a divalent metal cation for catalysis, with magnesium yielding optimal activity. Orf135 is most active on 5-methyl-dCTP (k(cat)/K(m) = 301,000 M(-1) s(-1)), followed by CTP (k(cat)/K(m) = 47,000 M(-1) s(-1)) and dCTP (k(cat)/K(m) = 18,000 M(-1) s(-1)) .

Researchers have also found that the Orf135 protein functions as a MutT-type enzyme that hydrolyzes 2-hydroxy-dATP (2-OH-dATP) and, less efficiently, 8-hydroxy-dGTP . This activity is crucial for suppressing spontaneous and hydrogen peroxide-induced mutations, as demonstrated by the two- to three-fold higher mutation frequencies in orf135- strains compared to wild-type strains .

How do ORF135 antibodies help researchers study nucleotide pool sanitization mechanisms?

ORF135 antibodies provide powerful tools for investigating the protein's role in nucleotide pool sanitization through several experimental approaches:

Experimental Design for Expression Analysis:

• Western blot analysis to quantify ORF135 expression levels during exposure to oxidizing agents (H₂O₂, paraquat)

• Comparison of expression patterns between wild-type strains and mutants with defects in oxidative stress response

• Time-course studies to track expression dynamics during stress and recovery phases

Correlation with Mutation Frequencies:

• Use antibodies to quantify ORF135 levels in strains with different mutation frequencies

• Examine how ORF135 expression correlates with levels of G:C→T:A transversions, the same type of mutation elicited by 2-OH-dATP

• Establish quantitative relationships between protein levels and mutation suppression

Protein-Substrate Interaction Studies:

• Immunoprecipitate ORF135 from cells exposed to different stressors

• Measure hydrolysis activity against oxidized deoxynucleotides

• Develop in vitro enzymatic assays using immunoprecipitated ORF135

Subcellular Localization:

• Track ORF135 localization under normal and stress conditions using immunofluorescence

• Investigate potential co-localization with DNA replication machinery

• Examine changes in localization in response to different types of DNA damage

What are the methodological considerations when developing specific antibodies against E. coli ORF135?

Developing specific antibodies against E. coli ORF135 requires careful consideration of several methodological aspects:

Antigen Design and Selection:

• Full-length protein vs. peptide antigens: While full-length ORF135 provides all potential epitopes, peptide antigens can be designed to target unique regions

• Avoid regions with high similarity to other Nudix hydrolases to prevent cross-reactivity

• Consider structural information to select exposed regions that are accessible in the native protein

Expression and Purification Strategy:

• ORF135 has been successfully cloned, overexpressed, and purified from E. coli

• Consider adding affinity tags (His-tag, GST) to facilitate purification

• Optimize expression conditions to ensure proper folding and maintain native epitopes

• Validate purified protein by activity assays to confirm functionality

Immunization and Screening:

• Use different host animals (mice, rabbits) for generating diverse antibody repertoires

• Implement suitable immunization schedules with appropriate adjuvants

• Screen antibodies against both recombinant ORF135 and native protein in E. coli lysates

• Include orf135- knockout strains as essential negative controls to confirm specificity

Monoclonal vs. Polyclonal Considerations:

• Monoclonal antibodies offer higher specificity and reproducibility but may recognize only a single epitope

• Polyclonal antibodies can detect multiple epitopes but may have batch-to-batch variation

• Consider the YCharOS approach for standardized characterization processes to enhance reproducibility

How can researchers validate the specificity of ORF135 antibodies in their experiments?

Thorough validation of ORF135 antibodies is crucial to ensure reliable research results. The following comprehensive validation approach is recommended:

Essential Western Blot Controls:

• Positive control: Purified recombinant ORF135 protein

• Negative control: Lysate from orf135 knockout strain

• Loading control: Antibody against a housekeeping protein for normalization

• Specificity control: Pre-immune serum or isotype control antibody

• Peptide competition: Pre-incubation of antibody with immunizing peptide/protein

Immunoprecipitation Validation:

• Immunoprecipitate ORF135 from bacterial lysates and confirm by mass spectrometry

• Perform reciprocal immunoprecipitation with tagged ORF135 constructs

• Include input controls, isotype controls, and knockout strain controls

• Test different lysis and washing conditions to optimize signal-to-noise ratio

Cross-Reactivity Assessment:

• Test against other purified Nudix hydrolases to assess potential cross-reactivity

• Compare signal patterns in wild-type vs. orf135 knockout lysates

• Develop a cross-reactivity matrix with other E. coli Nudix hydrolases

Epitope Mapping:

• Identify the specific epitope(s) recognized by the antibody

• Confirm that the epitope is unique to ORF135 compared to other Nudix hydrolases

• For monoclonal antibodies, determine if the epitope includes functionally important residues

What experimental approaches can be used with ORF135 antibodies to investigate its role in mutation suppression?

Several sophisticated experimental approaches can be employed with ORF135 antibodies to investigate its role in mutation suppression:

Complementation Studies:

• Express wild-type or mutant ORF135 in orf135- strains

• Use antibodies to confirm and quantify expression levels

• Correlate expression with restoration of mutation suppression function

• Example experimental design:

Expression Analysis Under Oxidative Stress:

• Quantify ORF135 expression levels by Western blot during exposure to H₂O₂

• Compare expression in wild-type vs. mutant strains with defects in oxidative stress response

• Track expression kinetics during recovery from oxidative stress

• Correlate ORF135 levels with mutation rates under different H₂O₂ concentrations

Structure-Function Studies:

• Use epitope-specific antibodies to probe structural changes under different conditions

• Perform limited proteolysis followed by epitope detection to examine conformational states

• Immunoprecipitate ORF135 before and after stress to assess structural modifications

Interaction with DNA Repair Machinery:

• Use immunofluorescence to examine potential co-localization with DNA polymerases

• Investigate recruitment to sites of DNA damage

• Conduct co-immunoprecipitation studies to identify potential interaction partners

What is the relationship between ORF135 and oxidative stress response, and how can antibodies help elucidate this connection?

The relationship between ORF135 and oxidative stress response can be investigated using antibodies through several methodological approaches:

Expression Dynamics During Oxidative Stress:

• Time-course analysis of ORF135 expression following H₂O₂ treatment

• Comparison of expression patterns across different oxidative stressors

• Correlation with expression of known oxidative stress response genes

Regulatory Mechanisms:

• Chromatin immunoprecipitation to identify transcription factors regulating ORF135

• Analysis of post-translational modifications that may regulate ORF135 activity during stress

• Investigation of protein stability and turnover under oxidative conditions

Functional Impact on Mutation Prevention:

• Quantitative analysis of mutation frequencies in strains with varying ORF135 levels

• Specifically, monitoring G:C→T:A transversions which are increased in orf135- strains

• Correlation of ORF135 levels with oxidized nucleotide accumulation

Experimental Data from Previous Studies:
Frequencies of spontaneous and H₂O₂-induced mutations were shown to be two- to three-fold higher in the orf135- strain than in the wild-type strain. These mutations include various mutations involving G:C→T:A transversions, the same type of mutation elicited by 2-OH-dATP. Over-expression of the Orf135 protein suppressed mutations even in the wild-type strain, as well as in the orf135- strain .

How can researchers distinguish between ORF135 and other Nudix hydrolases using antibody-based approaches?

Distinguishing between ORF135 and other Nudix hydrolases using antibodies presents challenges due to structural similarities. These challenges can be addressed through:

Epitope Selection Strategy:

• Carefully design immunogens targeting unique regions outside the conserved Nudix motif

• Use structural information to identify ORF135-specific exposed regions

• Focus on regions involved in substrate specificity for pyrimidine nucleotides

Comprehensive Validation Approach:

• Test against a panel of purified Nudix hydrolases to assess cross-reactivity

• Develop a cross-reactivity matrix with all known E. coli Nudix hydrolases

• Use orf135 knockout strains as essential negative controls

Epitope Mapping Techniques:

• Perform detailed epitope mapping using peptide arrays or mutagenesis

• Create a series of overlapping peptides to pinpoint the exact epitope

• Verify epitope uniqueness through sequence and structural alignments

Application-Specific Optimization:

• Optimize antibody conditions separately for each application (Western blot, IP, etc.)

• Establish clear positive/negative thresholds based on control experiments

• Consider developing application-specific antibodies if necessary

What controls are essential when using ORF135 antibodies in Western blot and immunoprecipitation experiments?

When using ORF135 antibodies in experiments, the following controls are essential:

Western Blot Controls:

• Positive control: Purified recombinant ORF135 protein

• Negative control: Lysate from orf135 knockout strain

• Loading control: Antibody against a housekeeping protein (e.g., GroEL)

• Specificity control: Pre-immune serum or isotype control antibody

• Peptide competition: Pre-incubation of antibody with immunizing peptide

• Signal validation: Secondary antibody-only control

Immunoprecipitation Controls:

• Input control: Sample of the lysate before immunoprecipitation

• Negative control: Immunoprecipitation with non-specific IgG

• Knockout control: Parallel immunoprecipitation from orf135- strain

• Reciprocal IP: Confirmation of interactions using antibodies against partners

• Antibody titration: Optimization of antibody concentration

Experimental Design Example:

How can researchers use E. coli expression systems to produce recombinant ORF135 protein for antibody development?

E. coli is an excellent expression system for producing recombinant ORF135 protein for antibody development, especially since ORF135 is naturally found in E. coli. The following methodological approach is recommended:

Vector and Strain Selection:

• Use expression vectors with strong inducible promoters (T7, tac)

• Add affinity tags (His-tag, GST) for easier purification

• Consider BL21(DE3) or its derivatives due to reduced protease activity

• When expressing ORF135, consider using an orf135 knockout strain to avoid contamination with endogenous protein

Optimization of Expression Conditions:

• Temperature: Lower temperatures (16-25°C) may improve solubility

• Induction: Optimize IPTG concentration and induction time

• Media: Rich media (LB) vs. defined media depending on downstream applications

• Scale-up considerations: Batch fermentation in bioreactors can achieve higher yields

Purification Strategy:

• Immobilized metal affinity chromatography (IMAC) for His-tagged proteins

• Consider additional purification steps (ion exchange, size exclusion)

• Assess protein purity using SDS-PAGE and Western blot

• Expected yields: 10-20 mg/L in shake flasks, up to 1-2 g/L in bioreactors

Quality Control:

• Verify protein identity by mass spectrometry

• Confirm enzymatic activity using substrate hydrolysis assays

• Ensure protein is properly folded using circular dichroism

• Test for endotoxin contamination if used for immunization

How can structural information about ORF135 guide the development of epitope-specific antibodies?

Structural information about ORF135 can significantly enhance the development of epitope-specific antibodies:

Identifying Accessible Surface Regions:

• Analyze the three-dimensional structure to identify solvent-exposed loops

• Prioritize regions with high accessibility for antibody binding

• Avoid buried residues that would not be accessible in the native protein

Targeting Unique Structural Features:

• Identify structural elements that are distinct from other Nudix hydrolases

• Focus on regions outside the conserved Nudix motif

• Consider regions involved in substrate specificity for pyrimidine nucleotides

Strategic Epitope Selection:

• For detection antibodies: Target regions away from the active site

• For inhibitory antibodies: Specifically target catalytic residues

• Consider the alkaline pH optimum of ORF135 and potential structural changes

Computational Approaches:

• Use structural information to predict optimal epitopes

• Perform molecular docking to predict antibody-antigen interactions

• Assess epitope uniqueness across the proteome to minimize cross-reactivity

Validation Strategy:

• Design point mutations based on structural information

• Create a panel of mutants to fine-map epitope residues

• Use hydrogen-deuterium exchange mass spectrometry to map binding sites